Little Heads, Big Pain: When Migraine Starts in Childhood

The Boy in the Dark Room

He’s seven. He’s lying on the bathroom floor because the tile is cool and everything else is too loud. His mother stands in the doorway, trying to decide if this is real.

It is.

Migraine is the leading cause of neurological disability in children and adolescents worldwide.^[1] Not one of many causes. The first. The Global Burden of Disease 2021 analysis — covering 204 countries and 37 neurological conditions — places migraine above every other neurological disorder in disability among young people.^{[1, 24]} It affects 1.16 billion people globally.^[1] Roughly one in nine children in any classroom has it.^[3]

And yet. Pediatric headache remains the most underfunded pediatric disease category when measured against public research dollars.^[2] The most disabling condition gets the least attention. That’s not a paradox. That’s a failure.

If you grew up with migraine, you know this failure intimately. You heard the words: You’re too young for headaches. It’s just growing pains. You’re looking for attention. If your child now holds their head and cries the same way you once did — this article exists so you never have to guess what’s happening again.

Before Puberty, It’s the Boys

Most people assume migraine is a woman’s disease. Before puberty, it’s the opposite.

Pre-pubertal boys have higher migraine prevalence than girls.^[4] The ratio flips after puberty, driven by estrogen fluctuations and shifts in follicle-stimulating hormone that amplify female migraine sensitivity.^[4] A school-based study found 10.4% of children met migraine criteria — and 1.7% already qualified as chronic, meaning 15 or more headache days per month.^[4]

Fifteen days. That’s every other day. In a child.

The damage compounds fast. Children with migraine miss an average of 7.8 school days per three-month period.^[5] In the US alone, pediatric migraine erases over 150,000 school days annually.^[6] Thirty-seven percent of children with migraine report poor performance during attacks; 46% of adolescent headache patients have documented school problems.^[7] And in clinical samples, 82% of adolescents with primary headache met criteria for a DSM psychiatric diagnosis — most commonly anxiety.^[8]

The Migraine That Hides in the Belly

A six-year-old doesn’t say, “I’m experiencing photophobia with unilateral throbbing pain.” A six-year-old says, “My tummy hurts.” And then nobody looks for migraine.

They should.

The International Classification of Headache Disorders (ICHD-3) recognizes several conditions in children that are migraine wearing a disguise — episodic syndromes that speak through an immature nervous system before the brain develops its adult dialect.^[9] The most common:

Abdominal migraine accounts for 4–15% of all pediatric gastroenterology referrals.^[10] Dull pain around the belly button. Moderate to severe. Lasts 2 to 72 hours. No headache — or not much of one. But follow these children forward, and up to 70% develop classic migraine by age 9 or 10.^[10] The belly pain wasn’t a mystery. It was a prologue.

Cyclic vomiting syndrome (CVS) brings intense, stereotypical episodes of nausea and vomiting in predictable cycles, with perfectly normal stretches in between.^[11] New 2025 clinical guidelines from NASPGHAN now strongly recommend anti-migraine agents as first-line abortive therapy for CVS in children with a personal or family history of migraine.^[11] That history is present in 82% of cases.^[12]

Now, the finding that reframes everything: CVS, abdominal migraine, and migraine headache may be three age-dependent phases of the same disorder.^[12] Vomiting dominates in the youngest children. Belly pain takes over in the middle years. Headache arrives last. Nearly 80% of children with CVS simultaneously meet diagnostic criteria for abdominal migraine.^[12] Same storm. Different windows.

Even infancy holds clues. Benign paroxysmal torticollis — spontaneous head tilting in babies — and benign paroxysmal vertigo — sudden episodes of dizziness in toddlers — are both now classified as migraine-associated syndromes.^{[4, 9]} If your infant had unexplained episodes of head tilting and distress, and you now live with migraine, there’s a connection nobody told you about.

A Different Brain, a Different Disease

A child’s brain is still under construction. That single fact changes everything about how migraine behaves in young patients.^[13]

Attacks are shorter. ICHD-3 sets the pediatric window at 2–72 hours, versus 4–72 in adults.^[9] A two-hour migraine is real migraine. Don’t dismiss it.

Pain spreads both ways. Adults typically feel migraine on one side. Children often feel it across both temples or the forehead^{[4, 9]} — which leads doctors straight to the wrong diagnosis: tension headache.

Words fail. Preschoolers can’t describe what they feel. Toddlers become irritable, cry without obvious cause, or demand a dark room.^[13] Infants may only show “head banging.”^[13] When a child can’t articulate pain, the pain becomes invisible.

The gut speaks first. Gut microbiota dysbiosis — an imbalance in the bacterial ecosystem of the intestines — is emerging as a contributor to pediatric migraine.^[4] The gut-brain axis communicates bidirectionally, and in children, it may explain why so many migraines first appear as gastrointestinal chaos before they ever become a headache.

The Year Everything Changed

For decades, treating migraine in children meant borrowing adult drugs, cutting doses in half, and hoping. In 2017, a landmark trial published in the New England Journal of Medicine delivered a devastating verdict: amitriptyline and topiramate — the two most widely prescribed preventives for pediatric migraine — were no more effective than placebo.^[14] Three hundred twenty-eight children. Multicenter. Double-blind. Placebo won.

That left families with almost nothing.

Then came August 2025. The FDA approved fremanezumab (Ajovy) for preventive treatment of episodic migraine in children aged 6–17 weighing at least 45 kg^[15] — the first and only CGRP-targeted therapy ever approved for pediatric migraine.^[15]

CGRP — calcitonin gene-related peptide — is the molecule at the center of modern migraine science. It drives the pain signaling and blood vessel dilation during an attack. Fremanezumab is a monoclonal antibody that binds CGRP before it can reach its receptors, interrupting the cascade at its source.^[16]

The Phase III SPACE trial enrolled 237 children, randomized and placebo-controlled.^[16] Fremanezumab reduced monthly migraine days by 2.5 versus 1.4 with placebo.^{[16, 17]} Nearly half — 47.2% — of treated children achieved at least a 50% reduction in migraine days, compared to 27% on placebo.^{[16, 17]} Safety matched the known adult profile: injection-site reactions, mostly.^[15]

What Works Without a Needle

The strongest non-drug evidence in pediatric migraine belongs to cognitive behavioral therapy. A randomized trial showed CBT combined with amitriptyline cut headache frequency and disability in children with chronic migraine, with improvements sustained in 86–88% of participants at one year.^{[4, 18]} A separate meta-analysis confirmed: CBT significantly reduces both frequency and disability in pediatric patients.^[4]

Beyond the therapist’s office, the evidence points to interventions so simple they’re easy to underestimate:

The Part That Doesn’t Fit in a Clinical Trial

There’s a wound that no drug addresses and no meta-analysis captures.

When you’re six and your head hurts so much you can’t play — and no one can see anything wrong — you start to wonder if something is wrong with you. When adults say it’s nothing, or you’re exaggerating, or you should try harder, you learn a devastating lesson: your pain doesn’t count.

Science is catching up to what lived experience always knew. Children with migraine show roughly a fourfold increase in internalizing disorders — anxiety, depression — compared to peers.^[8] The relationship runs both ways: migraine feeds anxiety, anxiety fuels migraine. In community studies, mental health remained poorer and school absence stayed higher at three-year follow-up.^[8]

But here’s where the research offers something unexpected. Self-compassion — directing warmth and kindness toward yourself in the face of suffering, rather than self-criticism — turns out to be measurably therapeutic. A systematic review of self-compassion in chronic pain found it associated with less pain interference, better social adjustment, and fewer depressive symptoms.^[21] Compassion-focused therapy helps people navigate chronic illness with greater resilience and adaptability.^[22] And a randomized controlled trial comparing a Mindful Self-Compassion program to CBT for chronic pain found the self-compassion group improved more in anxiety, pain acceptance, and emotional well-being.^[23]

To the Child You Were

There are things you deserved to hear.

Your pain was real. It was never “just a headache.” It was the most disabling neurological condition in your age group — confirmed by every global health analysis published since.^{[1, 24]} The adults around you didn’t have the language or the science. That was their limitation. Not yours.

You were not weak. You were doing something extraordinarily hard: growing up while managing a condition that brings adults to their knees. You’re still here.

And if you now have a child who holds their head the way you once did, or whose stomach knots in strange cyclical patterns, or who throws up on car rides no one else finds difficult — you understand something the rest of the world is only now learning.

You know what it feels like from inside.